The burden of diabetes is increasing rapidly in India, but a systematic understanding of its distribution and time trends is not available for every state of India. We present a comprehensive analysis of the time trends and heterogeneity in the distribution of diabetes burden across all states of India between 1990 and 2016. The increase in health loss from diabetes since 1990 in India is the highest among major non-communicable diseases.
September 12, 2018
The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016
September 12, 2018
The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990–2016
India has 18% of the global population and an increasing burden of chronic respiratory diseases. However, a systematic understanding of the distribution of chronic respiratory diseases and their trends over time is not readily available for all of the states of India. Our aim was to report the trends in the burden of chronic respiratory diseases and the heterogeneity in their distribution in all states of India between 1990 and 2016.
September 12, 2018
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016
Previous efforts to report estimates of cancer incidence and mortality in India and its different parts include the National Cancer Registry Programme Reports, Sample Registration System cause of death findings, Cancer Incidence in Five Continents Series, and GLOBOCAN. We present a comprehensive picture of the patterns and time trends of the burden of total cancer and specific cancer types in each state of India estimated as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 because such a systematic compilation is not readily available.
September 12, 2018
Gender differentials and state variations in suicide deaths in India: the Global Burden of Disease Study 1990–2016
A systematic understanding of suicide mortality trends over time at the subnational level for India’s 1.3 billion people, 18% of the global population, is not readily available. Thus, we aimed to report time trends of suicide deaths, and the heterogeneity in its distribution between the states of India from 1990 to 2016. India’s proportional contribution to global suicide deaths is high and increasing. The suicide death rate in India is higher than expected for its Socio-demographic Index level, especially for women, with substantial variations in the magnitude and men-to-women ratio between the states. India must develop a suicide prevention strategy that takes into account these variations in order to address this major public health problem.
August 30, 2018
The burden of disease in Russia from 1980 to 2016: a systematic analysis for the Global Burden of Disease Study 2016
Over the past few decades, social and economic changes have had substantial effects on health and well-being in Russia. We aimed to use data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to evaluate trends in mortality, causes of death, years lived with disability, years of life lost, disability-adjusted life years, and associated risk factors in Russia from 1980 to 2016.
August 29, 2018
Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Sustainable Development Goals (SDGs) mandate systematic monitoring of the health and well-being of all children to achieve optimal early childhood development. However, global epidemiological data on children with developmental disabilities are scarce. This study estimates prevalence and YLDs for epilepsy, intellectual disability, hearing loss, vision loss, autism spectrum disorder, and attention-deficit hyperactivity disorder for children younger than 5 years.
August 28, 2018
Understanding global variation in firearm mortality rates could guide prevention policies and interventions. This study estimated between 195,000 and 276,000 firearm injury deaths globally in 2016, the majority of which were firearm homicides. Despite an overall decrease in rates of firearm injury death since 1990, there was variation among countries and across demographic subgroups.
August 23, 2018
Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Alcohol use is a leading risk factor for global disease burden and causes substantial health loss. We found that the risk for all-cause mortality, and cancers specifically, rises with increasing levels of consumption, and the level of consumption that minimizes health loss is zero.
August 13, 2018
Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years
Rotavirus infection is the global leading cause of diarrhea-associated morbidity and mortality among children younger than 5 years. This report builds on findings from the Global Burden of Disease study 2016, a cross-sectional study that measured diarrheal diseases and their etiologic agents.
August 3, 2018
The Global Nutrient Database: availability of macronutrients and micronutrients in 195 countries from 1980 to 2013
Few data are available on the supply and consumption of nutrients at the country level. To address this data gap, we aimed to create a database that provides information on availability (i.e., supply) of 156 nutrients across 195 countries and territories from 1980 to 2013.
August 1, 2018
Burden of diseases and injuries in Afghanistan, 1990–2016: Findings From the Global Burden of Disease 2016 Study
This study aims to report the burden of diseases and injuries in Afghanistan between 1990 and 2016. Despite improvements in certain health indicators, our study suggests an urgent intervention to improve health status of the country. Improving health infrastructures, boosting maternal and child health (MCH), battling infectious diseases as well as chronic disease risk factor modification programs can help to decrease burden of diseases.
July 25, 2018
The burden of disease in Greece, health loss, risk factors, and health financing, 2000–16: an analysis of the Global Burden of Disease Study 2016
Following the economic crisis in Greece in 2010, the country's ongoing austerity measures include a substantial contraction of health care expenditure, with reports of subsequent negative health consequences. The findings of increases in total deaths and accelerated population aging call for specific focus from health policymakers to ensure the health care system is equipped to meet the needs of the people in Greece.
July 20, 2018
Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016
Political, economic, and epidemiological changes in Brazil have affected health and the health system. Health improved from 1990 to 2016, but improvements and disease burden varied between states. An epidemiological transition toward non-communicable diseases and related risks occurred nationally, but later in some states, while interpersonal violence grew as a health concern.
July 20, 2018
This study used the estimates of the GBD to summarise the state of health in Spain in 2016 and report trends in mortality and morbidity from 1990 to 2016.
June 28, 2018
On the road to universal health care in Indonesia, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
As Indonesia moves to provide health coverage for all citizens, understanding patterns of morbidity and mortality is important to allocate resources and address inequality.
June 13, 2018
Morbidity, mortality, and long-term consequences associated with diarrhea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study
The protozoan Cryptosporidium is a leading cause of diarrhea morbidity and mortality in children younger than 5 years. Our findings show that the substantial short-term burden of diarrhea from Cryptosporidium infection on childhood growth and well-being is an underestimate of the true burden.
June 4, 2018
Despite the long-standing recognition of antimicrobial resistance (AMR) across many settings, there is surprisingly poor information about its geographical distribution over time and trends in its population prevalence and incidence. The inclusion of mortality and morbidity data related to drug-resistant infections into the annual Global Burden of Disease Study should help fill this policy void.
June 2, 2018
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups, 1990 to 2016
The increasing burden due to cancer and other non-communicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) Global Action Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. This study assessed the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus.
May 23, 2018
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016
A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016.
May 16, 2018
Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease study 2016
Multiple myeloma (MM) is a plasma cell neoplasm with substantial morbidity and mortality. A comprehensive description of the global burden of MM is needed to help direct health policy, resource allocation, research, and patient care.